| Â |
Training group (n=5)
|
Validation group (n=16)
|
p
|
|---|
Median age | 70 (56–76) | 56.5 (49–72) | 0.068 |
CS III | 3 (60%) | 5 (33%) | 0.347 |
N(+) | 3 (60%) | 9 (60%) | 1.000 |
IDC | 5 (100%) | 10 (62%) | 0.262 |
ER(+) | 2 (40%) | 11 (69%) | 0.325 |
PR(+) | 3 (60%) | 9 (56%) | 1.000 |
HER2(+) | 2 (40%) | 5 (31%) | 1.000 |
- Tumor samples collected for tissue slices culture. Age in years; CS III: clinical stage III, AJCC 2002; IDC: invasive ductal carcinoma; N(+): lymph node positive involvement; ER: estrogen receptor immunoexpression; PR: progesterone receptor immunoexpression; HER2 immunoexpression (+): 3+/3+; (-): negative; (+): positive. p: Fisher exact test or Mann Whitney test.
